An Examination of Clinical and Immunologic Outcomes in Food Allergen Immunotherapy by Route of Administration

Current Allergy and Asthma Reports

Volumn 15, Issue 6, 2015, Pages

  Chiang, David ^a   Berin, M Cecilia ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Anaphylaxis; Desensitization; Food allergy; Tolerance

Indexed keywords

FOOD ALLERGEN; ALLERGEN;

ALLERGEN IMMUNOTHERAPY; CUTANEOUS DRUG ADMINISTRATION; DESENSITIZATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; EPICUTANEOUS IMMUNOTHERAPY; FOOD ALLERGY; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; MILK ALLERGY; ORAL IMMUNOTHERAPY; OUTCOME ASSESSMENT; PEANUT ALLERGY; PROVOCATION TEST; REVIEW; SUBLINGUAL IMMUNOTHERAPY; ANIMAL; FOOD HYPERSENSITIVITY; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; PROCEDURES; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ALLERGENS; ANIMALS; DESENSITIZATION, IMMUNOLOGIC; FOOD HYPERSENSITIVITY; HUMANS; SUBLINGUAL IMMUNOTHERAPY; TREATMENT OUTCOME;

EID: 84937433754     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-015-0536-y     Document Type: Review

References (51)

1. Fleischer DM, Perry TT, Atkins D, Wood RA, Burks AW, Jones SM, et al. Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study. Pediatrics. 2012;130(1):e25–32. doi:10.1542/peds.2011-1762.
2. Sicherer SH, Noone SA, Munoz-Furlong A. The impact of childhood food allergy on quality of life. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2001;87(6):461–4. doi:10.1016/S1081-1206(10)62258-2.
3. Nelson HS, Lahr J, Rule R, Bock A, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol. 1997;99(6 Pt 1):744–51.
4. Oppenheimer JJ, Nelson HS, Bock SA, Christensen F, Leung DY. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol. 1992;90(2):256–62.
5. Schofield A. A case of egg poisoning. Lancet. 1908;171(4410):716. doi:10.1016/S0140-6736(00)67313-0.
6. Edwards HE. Oral desensitization in food allergy. Can Med Assoc J. 1940;43(3):234–6.
7. Patriarca G, Schiavino D, Nucera E, Schinco G, Milani A, Gasbarrini GB. Food allergy in children: results of a standardized protocol for oral desensitization. Hepato-Gastroenterology. 1998;45(19):52–8.
8. Narisety SD, Frischmeyer-Guerrerio PA, Keet CA, Gorelik M, Schroeder J, Hamilton RG, et al. A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy. J Allergy Clin Immunol. 2014. doi:10.1016/j.jaci.2014.11.005. A direct comparison of the efficacy of SLIT and OIT for the treatment of peanut allergy.
9. Jones SM, Pons L, Roberts JL, Scurlock AM, Perry TT, Kulis M, et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol. 2009;124(2):292–300. doi:10.1016/j.jaci.2009.05.022.
10. Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, et al. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol. 2014;133(2):468–75. doi:10.1016/j.jaci.2013.11.007. A long-term follow up of subjects receiving peanut OIT up to five years, with assessment of maintenance of tolerance to peanut after discontinuation of OIT.
11. Blumchen K, Ulbricht H, Staden U, Dobberstein K, Beschorner J, de Oliveira LC, et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol. 2010;126(1):83–91. doi:10.1016/j.jaci.2010.04.030.
12. Varshney P, Jones SM, Scurlock AM, Perry TT, Kemper A, Steele P, et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol. 2011;127(3):654–60. doi:10.1016/j.jaci.2010.12.1111.
13. Burks AW, Jones SM, Wood RA, Fleischer DM, Sicherer SH, Lindblad RW, et al. Oral immunotherapy for treatment of egg allergy in children. N Engl J Med. 2012;367(3):233–43. doi:10.1056/NEJMoa1200435. A landmark multi-center double-blind randomized placebo-controlled study of OIT for egg that assessed outcomes including both desensitization and sustained unresponsiveness.
14. Buchanan AD, Green TD, Jones SM, Scurlock AM, Christie L, Althage KA, et al. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol. 2007;119(1):199–205. doi:10.1016/j.jaci.2006.09.016.
15. Keet CA, Frischmeyer-Guerrerio PA, Thyagarajan A, Schroeder JT, Hamilton RG, Boden S, et al. The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol. 2012;129(2):448–55. doi:10.1016/j.jaci.2011.10.023. 55 e1–5. A direct comparison of SLIT and two doses of OIT for the treatment of milk allergy, showing a dose effect on the induction of desensitization and sustained unresponsiveness.
16. Anagnostou K, Islam S, King Y, Foley L, Pasea L, Bond S, et al. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial. Lancet. 2014;383(9925):1297–304. doi:10.1016/S0140-6736(13)62301-6.
17. Caminiti L, Pajno GB, Crisafulli G, Chiera F, Collura M, Panasci G, et al. Oral immunotherapy for egg allergy: a double-blind placebo-controlled study, with postdesensitization follow-up. J Allergy Clin Immunol Pract. 2015. doi:10.1016/j.jaip.2015.01.017. A double-blind placebo-controlled study of egg OIT, followed by inclusion of egg into the diet and a sustained unresponsiveness challenge.
18. Skripak JM, Nash SD, Rowley H, Brereton NH, Oh S, Hamilton RG, et al. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow’s milk allergy. J Allergy Clin Immunol. 2008;122(6):1154–60. doi:10.1016/j.jaci.2008.09.030.
19. Sampson HA. Peanut oral immunotherapy: is it ready for clinical practice? J Allergy Clin Immunol Pract. 2013;1(1):15–21. doi:10.1016/j.jaip.2012.10.009.
20. Vazquez-Ortiz M, Alvaro-Lozano M, Alsina L, Garcia-Paba MB, Piquer-Gibert M, Giner-Munoz MT, et al. Safety and predictors of adverse events during oral immunotherapy for milk allergy: severity of reaction at oral challenge, specific IgE and prick test. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2013;43(1):92–102. doi:10.1111/cea.12012.
21. Vazquez-Ortiz M, Alvaro M, Piquer M, Dominguez O, Machinena A, Martin-Mateos MA, et al. Baseline specific IgE levels are useful to predict safety of oral immunotherapy in egg-allergic children. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2014;44(1):130–41. doi:10.1111/cea.12233.
22. Morais Silva P, Antunes J, Chambel M, Prates S, Leiria PP. Diagnosis of eosinophilic esophagitis in an infant undergoing milk oral immunotherapy—a case report. Eur Ann Allergy Clin Immunol. 2014;46(4):154–6.
23. Ridolo E, De Angelis GL, Dall’aglio P. Eosinophilic esophagitis after specific oral tolerance induction for egg protein. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2011;106(1):73–4. doi:10.1016/j.anai.2010.10.010.
24. Sanchez-Garcia S, Rodriguez Del Rio P, Escudero C, Martinez-Gomez MJ, Ibanez MD. Possible eosinophilic esophagitis induced by milk oral immunotherapy. J Allergy Clin Immunol. 2012;129(4):1155–7. doi:10.1016/j.jaci.2011.11.042.
25. Fuentes-Aparicio V, Alvarez-Perea A, Infante S, Zapatero L, D’Oleo A, Alonso-Lebrero E. Specific oral tolerance induction in paediatric patients with persistent egg allergy. Allergol Immunopathol. 2013;41(3):143–50. doi:10.1016/j.aller.2012.02.007.
26. Hofmann AM, Scurlock AM, Jones SM, Palmer KP, Lokhnygina Y, Steele PH, et al. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol. 2009;124(2):286–91. doi:10.1016/j.jaci.2009.03.045. 91 e1–6.
27. Lucendo AJ, Arias A, Tenias JM. Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2014;113(6):624–9. doi:10.1016/j.anai.2014.08.004.
28. Keet CA, Seopaul S, Knorr S, Narisety S, Skripak J, Wood RA. Long-term follow-up of oral immunotherapy for cow’s milk allergy. J Allergy Clin Immunol. 2013;132(3):737–9 e6. doi:10.1016/j.jaci.2013.05.006. This long-term follow-up of a milk OIT study provides data showing that successful completion of a sustained unresponsiveness challenge does not necessarily predict successful incorporation of milk into the diet, and highlights the need for long-term study of food immunotherapy outcomes.
29. Allam JP, Stojanovski G, Friedrichs N, Peng W, Bieber T, Wenzel J, et al. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy. 2008;63(6):720–7. doi:10.1111/j.1398-9995.2007.01611.x.
30. Kim EH, Bird JA, Kulis M, Laubach S, Pons L, Shreffler W, et al. Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol. 2011;127(3):640–6 e1. doi:10.1016/j.jaci.2010.12.1083.
31. Fleischer DM, Burks AW, Vickery BP, Scurlock AM, Wood RA, Jones SM, et al. Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol. 2013;131(1):119–27 e1-7. doi:10.1016/j.jaci.2012.11.011.
32. Chin SJ, Vickery BP, Kulis MD, Kim EH, Varshney P, Steele P, et al. Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison. J Allergy Clin Immunol. 2013;132(2):476–8 e2. doi:10.1016/j.jaci.2013.02.017.
33. Burks AW, Wood RA, Jones SM, Sicherer SH, Fleischer DM, Scurlock AM, et al. Sublingual immunotherapy for peanut allergy: long-term follow-up of a randomized multicenter trial. J Allergy Clin Immunol. 2015. doi:10.1016/j.jaci.2014.12.1917.
34. Dioszeghy V, Mondoulet L, Dhelft V, Ligouis M, Puteaux E, Benhamou PH, et al. Epicutaneous immunotherapy results in rapid allergen uptake by dendritic cells through intact skin and downregulates the allergen-specific response in sensitized mice. J Immunol. 2011;186(10):5629–37. doi:10.4049/jimmunol.1003134.
35. Tordesillas L, Goswami R, Benede S, Grishina G, Dunkin D, Jarvinen KM, et al. Skin exposure promotes a Th2-dependent sensitization to peanut allergens. J Clin Invest. 2014;124(11):4965–75. doi:10.1172/JCI75660.
36. Brough HA, Simpson A, Makinson K, Hankinson J, Brown S, Douiri A, et al. Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations. J Allergy Clin Immunol. 2014;134(4):867–75 e1. doi:10.1016/j.jaci.2014.08.011.
37. Fox AT, Sasieni P, du Toit G, Syed H, Lack G. Household peanut consumption as a risk factor for the development of peanut allergy. J Allergy Clin Immunol. 2009;123(2):417–23. doi:10.1016/j.jaci.2008.12.014.
38. Dioszeghy V, Mondoulet L, Dhelft V, Ligouis M, Puteaux E, Dupont C, et al. The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2014;44(6):867–81. doi:10.1111/cea.12312. This pre-clinical study shows that application of allergen by the epicutaneous route can generate regulatory tolerance and suppress allergic inflammation in the gastrointestinal tract.
39. Dupont C, Kalach N, Soulaines P, Legoue-Morillon S, Piloquet H, Benhamou PH. Cow’s milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity. J Allergy Clin Immunol. 2010;125(5):1165–7. doi:10.1016/j.jaci.2010.02.029.
40. Dupont C, Bourrier T, de Blay F, Guénard-Bilbault L, Sauvage C, Cousin M-O, et al. Peanut epicutaneous immunotherapy (EPIT) in peanut-allergic children: 18 months treatment in the Arachild Study. J Allergy Clin Immunol. 2014;133(2, Supplement):AB102. doi:10.1016/j.jaci.2013.12.381.
41. Sampson HA, Agbotounou W, Thébault C, Charles R, Martin L, Yang WH, et al. Epicutaneous immunotherapy (EPIT) is effective and safe to treat peanut allergy: a multi-national double-blind placebo-controlled randomized phase IIb trial. J Allergy Clin Immunol. 2015;135(2, Supplement):AB390. doi:10.1016/j.jaci.2014.12.1901.
42. Syed A, Garcia MA, Lyu SC, Bucayu R, Kohli A, Ishida S, et al. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J Allergy Clin Immunol. 2014;133(2):500–10. doi:10.1016/j.jaci.2013.12.1037. This mechanistic study identifies a key role of dendritic cells in determining the regulatory phenotype of T cells after OIT.
43. Gorelik M, Narisety SD, Guerrerio AL, Chichester KL, Keet CA, Bieneman AP, et al. Suppression of the immunologic response to peanut during immunotherapy is often transient. J Allergy Clin Immunol. 2014. doi:10.1016/j.jaci.2014.11.010. This mechanistic study shows that immune modifications induced by OIT and SLIT are not sustained, potentially explaining the need for maintained allergen exposure. Bystander effects of immunotherapy on basophil and T cell responses to dust mite are shown.
44. Frischmeyer-Guerrerio PA, Keet CA, Guerrerio AL, Chichester KL, Bieneman AP, Hamilton RG, et al. Modulation of dendritic cell innate and adaptive immune functions by oral and sublingual immunotherapy. Clin Immunol. 2014;155(1):47–59. doi:10.1016/j.clim.2014.08.006.
45. Thyagarajan A, Jones SM, Calatroni A, Pons L, Kulis M, Woo CS, et al. Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2012;42(8):1197–205. doi:10.1111/j.1365-2222.2012.04028.x.
46. Burton OT, Logsdon SL, Zhou JS, Medina-Tamayo J, Abdel-Gadir A, Noval Rivas M, et al. Oral immunotherapy induces IgG antibodies that act through FcgammaRIIb to suppress IgE-mediated hypersensitivity. J Allergy Clin Immunol. 2014;134(6):1310–7 e6. doi:10.1016/j.jaci.2014.05.042.
47. Bedoret D, Singh AK, Shaw V, Hoyte EG, Hamilton R, DeKruyff RH, et al. Changes in antigen-specific T-cell number and function during oral desensitization in cow’s milk allergy enabled with omalizumab. Mucosal Immunol. 2012;5(3):267–76. doi:10.1038/mi.2012.5.
48. Frischmeyer-Guerrerio PA, Guerrerio AL, Chichester KL, Bieneman AP, Hamilton RA, Wood RA, et al. Dendritic cell and T cell responses in children with food allergy. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2011;41(1):61–71. doi:10.1111/j.1365-2222.2010.03606.x.
49. Sallmann E, Reininger B, Brandt S, Duschek N, Hoflehner E, Garner-Spitzer E, et al. High-affinity IgE receptors on dendritic cells exacerbate Th2-dependent inflammation. J Immunol. 2011;187(1):164–71. doi:10.4049/jimmunol.1003392.
50. Zaleska A, Eiwegger T, Soyer O, van de Veen W, Rhyner C, Soyka MB, et al. Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine. Allergy. 2014;69(9):1162–70. doi:10.1111/all.12461.
51. Casale TB, Stokes JR. Immunotherapy: what lies beyond. J Allergy Clin Immunol. 2014;133(3):612–9. doi:10.1016/j.jaci.2014.01.007. quiz 20.